MILWAUKEE — The much-anticipated National League Division Series battle between managers Craig Counsell and Pat Murphy has been one-sided so far. Murphy has the decisive edge over his old friend and ...

No one messes with Jenny from the Block. Jennifer Lopez called out Craig Melvin after he asked the Grammy-nominated singer about her divorce from Ben Affleck during an interview with the “Today” show ...

Lopez was discussing her role in 'Kiss of the Spider Woman,' on which Affleck is an executive producer Rachel McRady is a Digital News Editor at PEOPLE. She has been an entertainment journalist for ...

Easton Cowan is expected to make the Maple Leafs' opening-night roster after strong camp performance. Coach Berube said, “I think he showed us enough that he is ready. He’s got a motor.” Cowan values ...

Feb 23, 2024; Mesa, Arizona, USA; Chicago Cubs manager Craig Counsell in the first inning against the Chicago White Sox at Sloan Park. Mandatory Credit: Rick Scuteri-USA TODAY Sports Game 1 of the ...

Toronto Maple Leafs head coach Craig Berube may have revealed his hand for opening night. In Monday’s “Maple Leafs Notebook,” Sportsnet’s Luke Fox reported that the Maple Leafs coach “rolled out” the ...

The Dallas Cowboys' Week 4 matchup against the Green Bay Packers didn't go the way anyone had hoped. Instead of getting bragging rights over Micah Parsons, the Cowboys would tie the Packers, in what ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...

Questions are being raised about Sarah Ferguson‘s income amid backlash over her ties to Jeffrey Epstein. Several charities linked to the Duchess of York moved to cut ties with her on Sept. 22 after ...

Eli Lilly & Co. halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons it didn’t disclose. Lilly closed the trial on ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...